Coeptis Therapeutics Holdings Inc (COEP)

$0.3

Market is closed - opens 7 PM, 17 Jul 2024

Performance

  • $0.30
    $0.31
    $0.30
    downward going graph

    1.6%

    Downside

    Day's Volatility :3.97%

    Upside

    2.41%

    downward going graph
  • $0.23
    $1.41
    $0.30
    downward going graph

    23.23%

    Downside

    52 Weeks Volatility :83.67%

    Upside

    78.72%

    downward going graph

Returns

PeriodCoeptis Therapeutics Holdings Inc
3 Months
-18.28%
6 Months
-44.02%
1 Year
-77.1%
3 Years
-93.68%

Highlights

Market Capitalization
11.2M
Book Value
$0.12
Earnings Per Share (EPS)
-0.51
Wall Street Target Price
3.0
Profit Margin
0.0%
Operating Margin TTM
0.0%
Return On Assets TTM
-145.68%
Return On Equity TTM
-577.82%
Revenue TTM
0.0
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
1563.7%
Gross Profit TTM
75.0K
EBITDA
-16.9M
Diluted Eps TTM
-0.51
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.26
EPS Estimate Next Year
-0.17
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
-0.09

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Coeptis Therapeutics Holdings Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
7
7
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 900.0%

Current $0.30
Target $3.00

Technicals Summary

Sell

Neutral

Buy

Coeptis Therapeutics Holdings Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Coeptis Therapeutics Holdings Inc
Coeptis Therapeutics Holdings Inc
-4.34%
-44.02%
-77.1%
-93.68%
-93.68%
Moderna, Inc.
Moderna, Inc.
-9.25%
24.7%
2.07%
-60.09%
791.95%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
4.75%
17.85%
51.74%
87.1%
265.7%
Novo Nordisk A/s
Novo Nordisk A/s
0.36%
32.05%
75.05%
218.96%
483.19%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
3.23%
12.73%
36.59%
145.42%
176.04%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Coeptis Therapeutics Holdings Inc
Coeptis Therapeutics Holdings Inc
NA
NA
NA
-0.26
-5.78
-1.46
NA
0.12
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.94
31.94
1.46
44.22
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
48.76
48.76
2.36
3.45
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.85
31.85
0.53
17.07
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Coeptis Therapeutics Holdings Inc
Coeptis Therapeutics Holdings Inc
Buy
$11.2M
-93.68%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$48.0B
791.95%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$119.2B
265.7%
31.94
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$633.1B
483.19%
48.76
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.7B
176.04%
31.85
39.46%

Institutional Holdings

  • Armistice Capital, LLC

    8.16%
  • Creative Planning Inc

    1.74%
  • Meteora Capital, LLC

    1.20%
  • Geode Capital Management, LLC

    0.51%
  • Vanguard Group Inc

    0.29%
  • CAMBRIDGE Invest RESEARCH ADVISORS, INC.

    0.15%

Company Information

Organization
Coeptis Therapeutics Holdings Inc
Employees
5
CEO
Mr. David Mehalick
Industry
Miscellaneous

FAQs